Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

16articles mentioning institutions

30institution mentions

1distinct institutions extracted

0%of mentions human-reviewed

Active filtersEntity: ESC ×

ESC

This institution is selected. Its supporting articles are shown below.

Articles mentioning ESC

16 articles · page 2 of 2

1-044 An evaluation of follow-up intervals in valve surveillance clinic

heartjnl · abstract · 2025-08-13 · 1 matching annotations

88.2%

BSE EACTS ESC BHVS valve surveillance clinic Valvular heart disease (VHD)medications

…aging tool in diagnosing and assessing the severity of VHD. The BSE, BHVS, ESC, and EACTS societies have outlined guidelines for op…

2-051 The use of glycoprotein IIb/IIIa inhibitors: slow-flow, no-flow only or do they still have a broader role, a district general hospital experience

heartjnl · abstract · 2025-08-13 · 1 matching annotations

78.3%

DGH district general hospital ESC ESC acute coronary syndrome ST-elevation myocardial infarction Glycoprotein IIb/IIIa inhibitors GPIs Chronic coronary syndrome non-ST elevation myocardial infarction+1 more

…ught to ascertain the adherence of a district general hospital (DGH) without 24 hour on-site PCI to such guidelines.Methods A retro…

7-007 Re-audit on the management of dyslipidaemia in patients presenting with acute myocardial infarction and the use of new lipid lowering therapies, are we meeting targets?

heartjnl · abstract · 2025-08-13 · 1 matching annotations

80.6%

Eur Heart J ESC district general hospital bempedoic acid Ezetimibe PCSK9 inhibitors acute myocardial infarction atherosclerosis Dyslipidaemia Atorvastatin

…slipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. https://academic.oup.com/eurheartj/article/41/1/111/5556353.Au…

Prevalence and risk factors of atherosclerotic cardiovascular disease in Egyptians with type 2 diabetes: findings from the PACT-MEA study and call for action

bmjopen · abstract · 2025-08-03 · 1 matching annotations

76.4%

ESC glucagon-like peptide-1 analogues sodium-glucose cotransporter-2 inhibitors eASCVD T2DM ASCVD Type 2 Diabetes

…risk patients as defined by the European Society of Cardiology (ESC) among the Egyptian population of the Prevalence and Clinical M…